- Report
- August 2026
- 114 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 174 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 484 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 512 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 154 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 183 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- August 2026
- 215 Pages
Global
From €5228EUR$5,850USD£4,469GBP
- Report
- January 2026
- 131 Pages
Global
From €4245EUR$4,750USD£3,628GBP
- Report
- January 2026
- 110 Pages
Global
From €4245EUR$4,750USD£3,628GBP
- Report
- February 2026
- 150 Pages
Global
From €3351EUR$3,750USD£2,864GBP
- Report
- January 2026
- 280 Pages
Global
From €2681EUR$3,000USD£2,292GBP
- Report
- January 2026
- 280 Pages
Global
From €2681EUR$3,000USD£2,292GBP
- Report
- November 2025
- 150 Pages
Global
From €3351EUR$3,750USD£2,864GBP
- Report
- November 2025
- 150 Pages
Global
From €3351EUR$3,750USD£2,864GBP
- Report
- April 2026
- 136 Pages
Global
From €2680EUR$2,999USD£2,291GBP
€3574EUR$3,999USD£3,055GBP
- Report
- June 2026
- 150 Pages
Global
From €4245EUR$4,750USD£3,628GBP
- Report
- April 2026
- 149 Pages
Global
From €2680EUR$2,999USD£2,291GBP
€3574EUR$3,999USD£3,055GBP
- Report
- May 2026
- 185 Pages
Global
From €4022EUR$4,500USD£3,437GBP
- Report
- August 2025
- 140 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- January 2026
- 149 Pages
Global
From €3530EUR$3,950USD£3,017GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more